Anus neoplasm
Showing 1 - 25 of 474
Anal Cancer Risk In Women
Recruiting
- Anal Cancer
- +4 more
- Dual Pathology
-
London, United Kingdom
- +1 more
Apr 19, 2023
Lymph Node Metastasis, Cancer of Rectum and Anus, Oxaliplatin Trial in Beijing (Experimental: FOLFOXIRI and Lateral lymph node
Enrolling by invitation
- Lymph Node Metastasis
- +6 more
- Experimental: FOLFOXIRI and Lateral lymph node dissection
- Preoperative long-term concurrent chemoradiotherapy and Lateral lymph node dissection
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences, Peking Uni
Sep 15, 2023
Tool to Describe HIV-Related Cancer Burden and Patient
Not yet recruiting
- HIV-Associated Malignant Neoplasm
- +7 more
- Non-Interventional
- Non-Interventional Follow-up
- (no location specified)
Aug 18, 2022
Pelvic Health, Sexual Function, and Quality of Life in Pelvic
Recruiting
- Anal Carcinoma
- +6 more
- Pelvic Examination
- Survey
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 1, 2021
Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive, Metastatic Malignant Tumor Trial in Houston (DNA
Active, not recruiting
- Human Papillomavirus-16 Positive
- +20 more
- DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457
- Durvalumab
-
Houston, TexasM D Anderson Cancer Center
Feb 11, 2022
Anal Tumor Trial in Chicago, New York, Québec (VGX-3100, CELLECTRA™ 5PSP)
Completed
- Anal Neoplasm
- VGX-3100
- CELLECTRA™ 5PSP
-
Chicago, Illinois
- +2 more
Dec 6, 2021
Malignant Tumor, Malignant Tumor of Rectum, Malignant Tumor of Anus Trial in Gothenburg (Capsules containing either dietary
Unknown status
- Malignant Neoplasm
- +9 more
- Capsules containing either dietary fiber or placebo
-
Gothenburg, SwedenJubileumskliniken, Sahlgrenska University Hospital
Sep 13, 2020
Metastatic HPV-16 Positive Squamous Cell Anal Cancer Trial run by the NCI (Cyclophosphamide, Fludarabine, Aldesleukin)
Withdrawn
- Metastatic HPV-16 Positive Squamous Cell Anal Cancer
- Cyclophosphamide
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 29, 2021
Stage IV Esophageal Adenocarcinoma, Stage IV Esophageal Squamous Cell Carcinoma, Stage IV Gastric Cancer Trial in San Francisco
Recruiting
- Stage IV Esophageal Adenocarcinoma
- +43 more
- Radiation Therapy (RT)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 29, 2022
HSIL, High-Grade Squamous Intraepithelial Lesions, Human Papilloma Virus Infection, HIV Infection Trial in Chicago, Darlinghurst
Terminated
- HSIL, High-Grade Squamous Intraepithelial Lesions
- +4 more
- Topical ABI-1968 cream
-
Chicago, Illinois
- +1 more
Jul 23, 2019
Anal Cancer, Tumor of Uncertain Malignant Potential, Nonneoplastic Condition Trial in United States (clinical observation,
Completed
- Anal Cancer
- +3 more
- clinical observation
- infrared photocoagulation therapy
-
Los Angeles, California
- +6 more
Jul 28, 2020
Anal Cancer Trial in Chicago, Houston (Practice Self-/Companion Exams, Control Arm)
Recruiting
- Anal Cancer
- Practice Self-/Companion Exams
- Control Arm
-
Chicago, Illinois
- +3 more
Oct 14, 2022
AIDS-Related Anal Carcinoma, AIDS-Related Cervical Carcinoma, High Grade Anal Intraepithelial Neoplasia Trial in San Francisco,
Recruiting
- AIDS-Related Anal Carcinoma
- +4 more
- Biopsy
- +5 more
-
San Francisco, California
- +2 more
Jan 24, 2023
Fecal Incontinence, Low Anterior Resection Syndrome, Malignant Anal Tumor Trial in Houston, Sugar Land (procedure, other,
Recruiting
- Fecal Incontinence
- +19 more
- Explantation
- +5 more
-
Houston, Texas
- +1 more
Aug 21, 2019
Colorectal Tumors, Colorectal Cancer Trial (3D colonoscopy)
Not yet recruiting
- Colorectal Neoplasms
- Colorectal Cancer
- 3D colonoscopy
- (no location specified)
Nov 29, 2021
Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted
Recruiting
- Acute Myeloid Leukemia
- +3 more
- CD123 targeted CAR-NK cells
-
Taiyuan, Shanxi, ChinaShanxi Bethune Hospital
Aug 28, 2023
Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong
Recruiting
- Myeloproliferative Neoplasm
- +7 more
-
Hong Kong, Hong KongDepartment of Medicine, Queen Mary Hospital
May 21, 2023
Rectum Cancer Trial (Plastic surgery of the pelvic floor and perineal wound with counter-displaced skin-subcutaneous fascial
Not yet recruiting
- Rectum Cancer
- Plastic surgery of the pelvic floor and perineal wound with counter-displaced skin-subcutaneous fascial flaps after extralevatory abdominal-perineal extirpation of the rectum
- +2 more
- (no location specified)
Oct 7, 2023
Hepatic Small Vessel Neoplasm
Not yet recruiting
- Hepatic Small Vessel Neoplasm
- Imaging
- (no location specified)
Oct 2, 2023
Rectal Cancer, Robotic, Anastomotic Leak Trial (Surform)
Not yet recruiting
- Rectal Cancer
- +3 more
- Surform
- (no location specified)
Dec 25, 2022
Squamous Cell Lung Cancer, Vulvar Cancer, Penile Cancer Trial in France (pembrolizumab; vorinostat)
Active, not recruiting
- Squamous Cell Lung Cancer
- +5 more
- pembrolizumab; vorinostat
-
Angers, France
- +13 more
Jan 4, 2023
Malignant Female Reproductive System Tumor Trial in Santo Domingo (Biospecimen Collection, Interview)
Recruiting
- Malignant Female Reproductive System Neoplasm
- Biospecimen Collection
- Interview
-
Santo Domingo, Dominican RepublicInstituto Dermatológico Dominicano y Cirugía de Piel (IDCP)
Nov 29, 2022
